"I did what?" Zolpidem and the courts

Journal of the American Academy of Psychiatry and the Law

Volumn 39, Issue 4, 2011, Pages 535-542

  Daley, Christopher ^a   Mcniel, Dale E ^a   Binder, Renée L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE; ZOLPIDEM;

CHEMICALLY INDUCED DISORDER; FORENSIC MEDICINE; HUMAN; LEGAL ASPECT; REVIEW; RISK FACTOR; SLEEP WALKING; VIOLENCE;

DANGEROUS BEHAVIOR; FORENSIC MEDICINE; HUMANS; HYPNOTICS AND SEDATIVES; PYRIDINES; RISK FACTORS; SOMNAMBULISM;

EID: 84856839502     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. FDA. NDA 19908 027 FDA approved labeling 4-23-08. Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019908s027lbl.pdf. Accessed March 1, 2010
2. Drug Topics. Top 200 brand-name drugs by units in 2006. Available at http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/092007/407649/article.pdf. Accessed March 4, 2010
3. Drug Topics. Top 200 brand-name drugs by retail dollars in 2006. Available at http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/072007/405100/article.pdf. Accessed February 18, 2010
4. FDA. FDA approves first generic version of Ambien (zolpidem tartrate) for the treatment of insomnia. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108897.htm. Accessed March 4, 2010
5. Drug Topics. 2008 Top 200 generic drugs by total prescriptions. Available at http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/222009/599844/article.pdf. Accessed March 4, 2010
6. Drug Topics. 2008 Top 200 generic drugs by retail dollars. Available at http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/092007/407649/article.pdf. Accessed March 4, 2010
7. Drug Topics. 2008 Top 200 branded drugs by total prescriptions. Available at http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/222009/599845/article.pdf. Accessed March 4, 2010
8. Dolder CR, Nelson MH: Hypnosedative-induced complex behaviors; incidence, mechanisms and management. CNS Drugs 22:1021-1036, 2008
9. Saul S: Record sales of sleeping pills causing worries. New York Times. Business Section. February 7, 2006, available at www.nytimes.com/2006/02/07/business/07sleep.html?pagewanted_all. Accessed October 11, 2011
10. Langtry HD, Benfield P: Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40:291-313, 1990
11. FDA. FDA requests label change for all sleep disorder drug products. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108868.htm. Accessed March 4, 2010
12. Sanna E, Businero F, Talani G, et al: Comparison of the effects of zaleplon, zolpidem and triazolam at various GABAA receptor subtypes. Eur J Pharmacol 451:103-110, 2002
13. Hoque R, Chesson AL: Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 5:471-476, 2009
14. Otmani S, Demazières A, Staner C, et al: Effects of prolongedrelease melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol 23: 693-705, 2008
15. Myers TP: Halcion made me do it: new liability and a new defense - fear and loathing in the Halcion paper chase. Univ Cin L Rev 62:603-653, 1993
16. Tsai JH, Yang P, Chen CC, et al: Zolpidem-induced amnesia and somnambulism: rare occurrences? Eur Neuropsychopharmacol 19:74-76, 2009
17. Morgenthaler TI, Silber MH: Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med 3:323-327, 2002
18. Najjar M: Zolpidem and amnestic sleep related eating disorder. J Clin Sleep Med 3:637-638, 2007
19. Sansone RA, Sansone LA: Zolpidem, somnambulism, and nocturnal eating. Gen Hosp Psychiatr 30:90-91, 2008
20. Doane JA, Dalpiaz AS: Zolpidem-induced sleep-driving. Am J Med 121:e5, 2008
21. Logan BK, Couper FJ: Zolpidem and driving impairment. J Forensic Sci 46:105-110, 2001
22. Siddiqui F, Osuna E, Chokroverty S: Writing emails as part of sleepwalking after increase in zolpidem. Sleep Med 10:262-264, 2009
23. Cartwright R: Sleepwalking violence: a sleep disorder, a legal dilemma and a psychological challenge. Am J Psychiatr 161:1149-1158, 2004
24. Le Bon O, Neu D: Total absence of recall of discussion occurred shortly after ingestion of 10mg of zolpidem. Pharmacopsychiatry 42:126-127, 2009
25. Yang W, Dollear M, Muthukrishnan SR: One rare side effect of zolpidem-sleepwalking: a case report. Arch Phys Med Rehabil 86:1265-1266, 2005
26. Feinberg I, Maloney T, Campbell IG: Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatr Res 34:423-438, 2000
27. Lam SP, Fong SYY, Ho CKW, et al: Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatr 69:1374-1382, 2008
28. Sharma A, Dewan VK: A case report of zolpidem-induced somnambulism. J Clin Psychiatr 7:74, 2005
29. Pressmen MR: Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev 11:5-30, 2007
30. Bingham v. State, No. 49A04-0808-CR-504 (Ind. App. 2009)
31. People v. Chaffey, 25 Cal. App. 4th 852 (Cal. Ct. App. 1994)
32. Kelly v. Salt Lake City Civil Service Commission, 8 P.3d 1048 (Utah Ct. App. 2000)
33. People v. Johns, No. G040874 (Cal. 4th App. 2009)
34. People v. Hudon, No. D054442 (Cal. 4th App. 2009)
35. State v. Hoy, 219 S.W.3d 796 (Mo. Ct. App. 2007)
36. People v. Walden, No. 08CA0859 (Colo. App. 2009)
37. Gibson v. Sanofi-Aventis U.S, LLC, 2009 U.S. Dist LEXIS 102864 (W.D. Ky. 2009)
38. Bradley v. Commonwealth of Virginia, No. 1443-08-4 (Va. App. 2009)
39. Davidson v. State, 849 N.E.2d 591 (Ind. 2006)
40. Lee-Chiong TL: Parasomnias and other sleep-related movement disorders. Prim Care 32:415-434, 2005
41. Victorri-Vigneau C, Dailly E, Jolliet V, et al: Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198-209, 2007
42. Whyte J, Myers R: Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness, a preliminary placebo controlled trial. Am J Phys Med Rehabil 88: 410-418, 2009
43. An NHS Trust v. J, 94 BMLR 15 (UK 2006)